CN Stock MarketDetailed Quotes

605507 Guobang Pharma Ltd.

Watchlist
  • 20.44
  • +0.03+0.15%
Market Closed Nov 18 15:00 CST
11.42BMarket Cap16.26P/E (TTM)

Guobang Pharma Ltd. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
9.00%4.42B
2.94%2.89B
-5.07%1.34B
-6.49%5.35B
-1.46%4.05B
3.93%2.81B
19.90%1.41B
26.98%5.72B
28.01%4.11B
20.56%2.7B
Operating revenue
9.00%4.42B
2.94%2.89B
-5.07%1.34B
-6.49%5.35B
-1.46%4.05B
3.93%2.81B
19.90%1.41B
26.98%5.72B
28.01%4.11B
20.56%2.7B
Other operating revenue
----
96.15%14.62M
----
28.96%22.35M
----
-6.10%7.45M
----
39.43%17.33M
----
114.71%7.94M
Total operating cost
7.07%3.72B
0.90%2.4B
-6.76%1.1B
-0.21%4.65B
5.92%3.48B
11.64%2.38B
27.03%1.18B
27.27%4.66B
26.07%3.28B
18.00%2.13B
Operating cost
6.81%3.26B
0.27%2.12B
-6.13%971.46M
-1.15%4.1B
3.67%3.05B
11.26%2.12B
27.67%1.03B
31.68%4.14B
32.76%2.95B
22.58%1.9B
Operating tax surcharges
38.82%32.09M
17.46%19.37M
-13.15%6.98M
9.37%36.19M
3.31%23.12M
28.54%16.49M
42.24%8.03M
31.99%33.09M
21.99%22.38M
8.87%12.83M
Operating expense
-6.28%50.47M
-0.76%32.25M
12.29%17.23M
15.66%74.2M
37.55%53.85M
26.43%32.49M
3.72%15.34M
14.84%64.15M
-29.04%39.15M
-23.55%25.7M
Administration expense
-0.63%228.09M
-1.21%150.61M
-0.76%75.75M
3.40%303.08M
9.69%229.55M
19.59%152.45M
16.97%76.32M
15.62%293.11M
12.71%209.28M
9.40%127.48M
Financial expense
81.44%-8.33M
47.91%-21.1M
-469.45%-8.97M
31.95%-46.28M
33.54%-44.9M
-46.50%-40.51M
-289.42%-1.57M
-342.43%-68.01M
-424.60%-67.55M
-234.76%-27.65M
-Interest expense (Financial expense)
18.87%21.64M
55.76%14.77M
40.97%7.42M
36.46%22.58M
40.00%18.2M
105.55%9.49M
148.91%5.27M
-42.38%16.55M
-43.29%13M
-74.01%4.61M
-Interest Income (Financial expense)
40.54%-24.66M
35.06%-19.4M
34.73%-10.77M
-76.34%-51.78M
-138.81%-41.48M
-309.92%-29.87M
-444.03%-16.5M
-59.76%-29.36M
-75.00%-17.37M
-39.56%-7.29M
Research and development
-1.52%160.29M
-4.60%92.96M
-19.64%37.65M
-3.56%190.51M
20.51%162.76M
12.51%97.44M
48.02%46.86M
27.22%197.54M
27.16%135.06M
26.55%86.61M
Credit Impairment Loss
31.77%-13.52M
-194.10%-13.88M
-72.58%-4.49M
137.76%4.72M
-283.71%-19.81M
33.58%-4.72M
68.89%-2.6M
-1,258.59%-12.5M
-4,282.00%-5.16M
-54.07%-7.11M
Asset Impairment Loss
-4,234.47%-54.05M
-161.73%-44.54M
-764.96%-8.83M
-13.50%-31.45M
87.26%-1.25M
-114.23%-17.02M
87.08%-1.02M
46.54%-27.71M
53.28%-9.79M
-2,995.78%-7.94M
Other net revenue
-78.89%-19.58M
-38.65%-22.69M
-1,030.25%-2.5M
332.98%7.64M
-197.41%-10.95M
-606.56%-16.37M
103.49%268.79K
89.49%-3.28M
202.61%11.24M
286.62%3.23M
Fair value change income
--10.14M
59.77%5.81M
---380.32K
126.89%10.34M
----
--3.64M
----
-27.15%4.56M
----
----
Invest income
145.14%11.45M
811.66%10.28M
214.11%7.27M
-32.33%13.22M
-75.50%4.67M
-111.51%-1.44M
-61.50%2.31M
356.92%19.54M
1,832.38%19.07M
3,101.68%12.55M
-Including: Investment income associates
14.93%-1.3M
-57.78%-453.32K
-70.06%-695.27K
108.12%60.46K
-75.65%-1.53M
63.42%-287.31K
18.70%-408.83K
52.29%-744.63K
-46.54%-871.48K
-32.07%-785.45K
Asset deal income
--2.26K
--2.26K
----
----
----
----
----
-99.99%44.63
----
----
Other revenue
385.33%26.39M
517.73%19.64M
149.33%3.94M
-15.87%10.8M
-23.60%5.44M
-44.48%3.18M
-38.35%1.58M
19.62%12.84M
-17.96%7.12M
0.92%5.73M
Operating profit
19.50%673.95M
13.16%472.46M
2.41%236.11M
-33.30%702.26M
-32.89%563.98M
-27.84%417.52M
-3.77%230.55M
30.18%1.05B
40.74%840.33M
31.57%578.62M
Add:Non operating Income
62.30%3.44M
589.25%2.6M
113.16%482.07K
489.23%3.32M
127.98%2.12M
-35.51%377.86K
-30.73%226.15K
-94.18%562.61K
-90.75%928.6K
-63.46%585.88K
Less:Non operating expense
94.90%12.75M
120.03%10.97M
19.60%2.56M
-55.45%7.93M
-39.56%6.54M
-54.94%4.99M
-55.44%2.14M
52.67%17.8M
79.46%10.82M
154.53%11.07M
Total profit
18.78%664.63M
12.40%464.09M
2.36%234.02M
-32.64%697.65M
-32.62%559.55M
-27.32%412.91M
-2.75%228.63M
28.37%1.04B
38.16%830.44M
30.00%568.14M
Less:Income tax cost
19.61%85.99M
6.55%59.72M
5.30%35.44M
-23.78%87.67M
-34.09%71.89M
-23.37%56.05M
-3.26%33.66M
14.39%115.02M
37.32%109.08M
23.98%73.14M
Net profit
18.66%578.64M
13.31%404.37M
1.85%198.58M
-33.74%609.98M
-32.40%487.66M
-27.91%356.86M
-2.66%194.97M
30.36%920.62M
38.28%721.36M
30.94%495M
Net profit from continuing operation
18.66%578.64M
13.31%404.37M
1.85%198.58M
-33.74%609.98M
-32.40%487.66M
-27.91%356.86M
-2.66%194.97M
30.36%920.62M
38.28%721.36M
30.94%495M
Less:Minority Profit
82.59%-246.74K
62.74%-228.91K
-144.57%-152.44K
-780.84%-2.49M
-586.07%-1.42M
-1,318.46%-614.41K
488.30%342.02K
-241.63%-282.17K
-48.41%291.63K
-112.69%-43.32K
Net profit of parent company owners
18.36%578.88M
13.18%404.6M
2.11%198.73M
-33.49%612.46M
-32.17%489.07M
-27.79%357.47M
-2.88%194.63M
30.43%920.9M
38.38%721.06M
31.07%495.04M
Earning per share
Basic earning per share
18.18%1.04
14.06%0.73
2.86%0.36
-33.33%1.1
-31.78%0.88
-28.09%0.64
-2.78%0.35
19.57%1.65
21.70%1.29
11.25%0.89
Diluted earning per share
18.18%1.04
14.06%0.73
2.86%0.36
-33.33%1.1
-31.78%0.88
-28.09%0.64
-2.78%0.35
19.57%1.65
21.70%1.29
11.25%0.89
Other composite income
Total composite income
18.66%578.64M
13.31%404.37M
1.85%198.58M
-33.74%609.98M
-32.40%487.66M
-27.91%356.86M
-2.66%194.97M
30.36%920.62M
38.28%721.36M
30.94%495M
Total composite income of parent company owners
18.36%578.88M
13.18%404.6M
2.11%198.73M
-33.49%612.46M
-32.17%489.07M
-27.79%357.47M
-2.88%194.63M
30.43%920.9M
38.38%721.06M
31.07%495.04M
Total composite income of minority owners
82.59%-246.74K
62.74%-228.91K
-144.57%-152.44K
-780.84%-2.49M
-586.07%-1.42M
-1,318.46%-614.41K
488.30%342.02K
-241.63%-282.17K
-48.41%291.63K
-112.69%-43.32K
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 9.00%4.42B2.94%2.89B-5.07%1.34B-6.49%5.35B-1.46%4.05B3.93%2.81B19.90%1.41B26.98%5.72B28.01%4.11B20.56%2.7B
Operating revenue 9.00%4.42B2.94%2.89B-5.07%1.34B-6.49%5.35B-1.46%4.05B3.93%2.81B19.90%1.41B26.98%5.72B28.01%4.11B20.56%2.7B
Other operating revenue ----96.15%14.62M----28.96%22.35M-----6.10%7.45M----39.43%17.33M----114.71%7.94M
Total operating cost 7.07%3.72B0.90%2.4B-6.76%1.1B-0.21%4.65B5.92%3.48B11.64%2.38B27.03%1.18B27.27%4.66B26.07%3.28B18.00%2.13B
Operating cost 6.81%3.26B0.27%2.12B-6.13%971.46M-1.15%4.1B3.67%3.05B11.26%2.12B27.67%1.03B31.68%4.14B32.76%2.95B22.58%1.9B
Operating tax surcharges 38.82%32.09M17.46%19.37M-13.15%6.98M9.37%36.19M3.31%23.12M28.54%16.49M42.24%8.03M31.99%33.09M21.99%22.38M8.87%12.83M
Operating expense -6.28%50.47M-0.76%32.25M12.29%17.23M15.66%74.2M37.55%53.85M26.43%32.49M3.72%15.34M14.84%64.15M-29.04%39.15M-23.55%25.7M
Administration expense -0.63%228.09M-1.21%150.61M-0.76%75.75M3.40%303.08M9.69%229.55M19.59%152.45M16.97%76.32M15.62%293.11M12.71%209.28M9.40%127.48M
Financial expense 81.44%-8.33M47.91%-21.1M-469.45%-8.97M31.95%-46.28M33.54%-44.9M-46.50%-40.51M-289.42%-1.57M-342.43%-68.01M-424.60%-67.55M-234.76%-27.65M
-Interest expense (Financial expense) 18.87%21.64M55.76%14.77M40.97%7.42M36.46%22.58M40.00%18.2M105.55%9.49M148.91%5.27M-42.38%16.55M-43.29%13M-74.01%4.61M
-Interest Income (Financial expense) 40.54%-24.66M35.06%-19.4M34.73%-10.77M-76.34%-51.78M-138.81%-41.48M-309.92%-29.87M-444.03%-16.5M-59.76%-29.36M-75.00%-17.37M-39.56%-7.29M
Research and development -1.52%160.29M-4.60%92.96M-19.64%37.65M-3.56%190.51M20.51%162.76M12.51%97.44M48.02%46.86M27.22%197.54M27.16%135.06M26.55%86.61M
Credit Impairment Loss 31.77%-13.52M-194.10%-13.88M-72.58%-4.49M137.76%4.72M-283.71%-19.81M33.58%-4.72M68.89%-2.6M-1,258.59%-12.5M-4,282.00%-5.16M-54.07%-7.11M
Asset Impairment Loss -4,234.47%-54.05M-161.73%-44.54M-764.96%-8.83M-13.50%-31.45M87.26%-1.25M-114.23%-17.02M87.08%-1.02M46.54%-27.71M53.28%-9.79M-2,995.78%-7.94M
Other net revenue -78.89%-19.58M-38.65%-22.69M-1,030.25%-2.5M332.98%7.64M-197.41%-10.95M-606.56%-16.37M103.49%268.79K89.49%-3.28M202.61%11.24M286.62%3.23M
Fair value change income --10.14M59.77%5.81M---380.32K126.89%10.34M------3.64M-----27.15%4.56M--------
Invest income 145.14%11.45M811.66%10.28M214.11%7.27M-32.33%13.22M-75.50%4.67M-111.51%-1.44M-61.50%2.31M356.92%19.54M1,832.38%19.07M3,101.68%12.55M
-Including: Investment income associates 14.93%-1.3M-57.78%-453.32K-70.06%-695.27K108.12%60.46K-75.65%-1.53M63.42%-287.31K18.70%-408.83K52.29%-744.63K-46.54%-871.48K-32.07%-785.45K
Asset deal income --2.26K--2.26K---------------------99.99%44.63--------
Other revenue 385.33%26.39M517.73%19.64M149.33%3.94M-15.87%10.8M-23.60%5.44M-44.48%3.18M-38.35%1.58M19.62%12.84M-17.96%7.12M0.92%5.73M
Operating profit 19.50%673.95M13.16%472.46M2.41%236.11M-33.30%702.26M-32.89%563.98M-27.84%417.52M-3.77%230.55M30.18%1.05B40.74%840.33M31.57%578.62M
Add:Non operating Income 62.30%3.44M589.25%2.6M113.16%482.07K489.23%3.32M127.98%2.12M-35.51%377.86K-30.73%226.15K-94.18%562.61K-90.75%928.6K-63.46%585.88K
Less:Non operating expense 94.90%12.75M120.03%10.97M19.60%2.56M-55.45%7.93M-39.56%6.54M-54.94%4.99M-55.44%2.14M52.67%17.8M79.46%10.82M154.53%11.07M
Total profit 18.78%664.63M12.40%464.09M2.36%234.02M-32.64%697.65M-32.62%559.55M-27.32%412.91M-2.75%228.63M28.37%1.04B38.16%830.44M30.00%568.14M
Less:Income tax cost 19.61%85.99M6.55%59.72M5.30%35.44M-23.78%87.67M-34.09%71.89M-23.37%56.05M-3.26%33.66M14.39%115.02M37.32%109.08M23.98%73.14M
Net profit 18.66%578.64M13.31%404.37M1.85%198.58M-33.74%609.98M-32.40%487.66M-27.91%356.86M-2.66%194.97M30.36%920.62M38.28%721.36M30.94%495M
Net profit from continuing operation 18.66%578.64M13.31%404.37M1.85%198.58M-33.74%609.98M-32.40%487.66M-27.91%356.86M-2.66%194.97M30.36%920.62M38.28%721.36M30.94%495M
Less:Minority Profit 82.59%-246.74K62.74%-228.91K-144.57%-152.44K-780.84%-2.49M-586.07%-1.42M-1,318.46%-614.41K488.30%342.02K-241.63%-282.17K-48.41%291.63K-112.69%-43.32K
Net profit of parent company owners 18.36%578.88M13.18%404.6M2.11%198.73M-33.49%612.46M-32.17%489.07M-27.79%357.47M-2.88%194.63M30.43%920.9M38.38%721.06M31.07%495.04M
Earning per share
Basic earning per share 18.18%1.0414.06%0.732.86%0.36-33.33%1.1-31.78%0.88-28.09%0.64-2.78%0.3519.57%1.6521.70%1.2911.25%0.89
Diluted earning per share 18.18%1.0414.06%0.732.86%0.36-33.33%1.1-31.78%0.88-28.09%0.64-2.78%0.3519.57%1.6521.70%1.2911.25%0.89
Other composite income
Total composite income 18.66%578.64M13.31%404.37M1.85%198.58M-33.74%609.98M-32.40%487.66M-27.91%356.86M-2.66%194.97M30.36%920.62M38.28%721.36M30.94%495M
Total composite income of parent company owners 18.36%578.88M13.18%404.6M2.11%198.73M-33.49%612.46M-32.17%489.07M-27.79%357.47M-2.88%194.63M30.43%920.9M38.38%721.06M31.07%495.04M
Total composite income of minority owners 82.59%-246.74K62.74%-228.91K-144.57%-152.44K-780.84%-2.49M-586.07%-1.42M-1,318.46%-614.41K488.30%342.02K-241.63%-282.17K-48.41%291.63K-112.69%-43.32K
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data